DUBLIN--(BUSINESS WIRE)--The "Graves' Disease - Market Insight, Epidemiology and Market Forecast -2030" report has been added to ResearchAndMarkets.com's offering.
The Graves' Disease market report provides current treatment practices, emerging drugs, Graves' Disease market share of the individual therapies, current and forecasted Graves' Disease market Size from 2018 to 2030 segmented by seven major markets. The Report also covers current Graves' Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate the best of the opportunities and assesses the underlying potential of the market.
Graves' Disease Epidemiology
The Graves' Disease epidemiology division provide insights about historical and current Graves' Disease patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Key Findings
The disease epidemiology covered in the report provides historical as well as forecasted Graves' Disease epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2018 to 2030.
Country Wise- Graves' Disease Epidemiology
The epidemiology segment also provides the Graves' Disease epidemiology data and findings across the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
Graves' Disease Drug Chapters
The drug chapter segment of the Graves' Disease report encloses the detailed analysis of Graves' Disease marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Graves' Disease clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.
Marketed Drugs
The report provides the details of the marketed product available for Graves' Disease treatment.
Graves' Disease Emerging Drugs
The report provides the details of the emerging therapies under the late and mid-stage of development for Graves' Disease treatment.
Graves' Disease Market Outlook
The Graves' Disease market outlook of the report helps to build a detailed comprehension of the historic, current and forecasted Graves' Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology.
This segment gives a thorough detail of Graves' Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria's, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated market data are presented with relevant tables and graphs to give a clear view of the market at first sight.
Key Topics Covered:
1. Key Insights
2. Executive Summary of Graves' Disease
3. Competitive Intelligence Analysis for Graves' Disease
4. Graves' Disease: Market Overview at a Glance
4.1. Graves' Disease Total Market Share (%) Distribution in 2018
4.2. Graves' Disease Total Market Share (%) Distribution in 2030
5. Graves' Disease: Disease Background and Overview
5.1. Introduction
5.2. Sign and Symptoms
5.3. Pathophysiology
5.4. Risk Factors
5.5. Diagnosis
6. Patient Journey
7. Graves' Disease Epidemiology and Patient Population
7.1. Epidemiology Key Findings
7.2. Assumptions and Rationale: 7MM
7.3. Epidemiology Scenario: 7MM
7.3.1. Graves' Disease Epidemiology Scenario in the 7MM (2018-2030)
7.4. United States Epidemiology
7.4.1. Graves' Disease Epidemiology Scenario in the United States (2018-2030)
7.5. EU-5 Country-wise Epidemiology
7.5.1. Germany Epidemiology
7.5.2. France Epidemiology
7.5.3. Italy Epidemiology
7.5.4. Spain Epidemiology
7.5.5. United Kingdom Epidemiology
7.5.6. Japan Epidemiology
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Graves' Disease Treatment and Management
8.2. Graves' Disease Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Graves' Disease Treatment
11. Marketed Products
11.1. List of Marketed Products in the 7MM
11.2. Drug Name: Company Name
11.2.1. Product Description
11.2.2. Regulatory Milestones
11.2.3. Other Developmental Activities
11.2.4. Pivotal Clinical Trials
11.2.5. Summary of Pivotal Clinical Trial
12. Emerging Therapies
12.1. Key Cross
12.2. Drug Name: Company Name
12.2.1. Product Description
12.2.2. Other Developmental Activities
12.2.3. Clinical Development
12.2.4. Safety and Efficacy
12.2.5. Product Profile
13. Graves' Disease: Seven Major Market Analysis
13.1. Key Findings
13.2. Graves' Disease Market Size in 7MM
13.3. Graves' Disease Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
15.1. United States: Market Size
15.1.1. Graves' Disease Total Market Size in the United States
15.1.2. Graves' Disease Market Size by Therapies in the United States
15.2. EU-5 countries: Market Size and Outlook
15.3. Germany Market Size
15.3.1. Graves' Disease Total Market Size in Germany
15.3.2. Graves' Disease Market Size by Therapies in Germany
15.4. France Market Size
15.5. Italy Market Size
15.6. Spain Market Size
15.7. United Kingdom Market Size
15.8. Japan Market Outlook
16. Access and Reimbursement Overview of Graves' Disease
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/72wbkw
